# HCC Response Assessment by MRI After SBRT

> **NCT03088423** · — · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 35 (actual)

## Conditions studied

- Carcinoma, Hepatocellular

## Interventions

- **RADIATION:** SBRT delivers high dose selective irradiation with millimeter precision to a small volume. The Cyberknife® is a robotic SBRT dedicated device that can deliver 100 to 200 photobeams to the target

## Key facts

- **NCT ID:** NCT03088423
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-01
- **Primary completion:** 2013-04-01
- **Final completion:** 2015-02-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03088423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03088423, "HCC Response Assessment by MRI After SBRT". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03088423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*